Erratum: Oroxylin A sensitizes non-small cell lung cancer cells to anoikis via glucose-deprivation-like mechanisms: C-Src and hexokinase II (Biochimica et Biophysica Acta - General Subjects (2013) 1830 (2835-2845) DOI: 10.1016/j.bbagen.2013.03.009);Oroxylin A sensitizes non-small cell lung cancer cells to anoikis via glucose-deprivation-like mechanisms: C-Src and hexokinase II

Biochimica et Biophysica Acta - General Subjects

Volumn 1830, Issue 6, 2013, Pages 3835-3845

  Wei, Libin ^a   Dai, Qinsheng ^a   Zhou, Yuxin ^a   Zou, Meijuan ^a   Li, Zhiyu ^a   Lu, Na ^a   Guo, Qinglong ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Anoikis; c Src; Glycolysis; Hexokinase II; Oroxylin A

Indexed keywords

ADENOSINE TRIPHOSPHATE; HEXOKINASE; HEXOKINASE ISOENZYME; OROXYLIN A; PROTEIN KINASE B; PROTEIN KINASE P60; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANOIKIS; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER RESISTANCE; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME INACTIVATION; ENZYME PHOSPHORYLATION; GLYCOLYSIS; IN VITRO STUDY; IN VIVO STUDY; LUNG METASTASIS; LUNG NON SMALL CELL CANCER; MALE; METASTASIS INHIBITION; MITOCHONDRION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

MURINAE; MUS MUSCULUS;

EID: 84876937174     PISSN: 03044165     EISSN: 18728006     Source Type: Journal    
DOI: 10.1016/j.bbagen.2014.07.007     Document Type: Erratum

References (58)

1. M. Yilmaz, and G. Christofori EMT, the cytoskeleton, and cancer cell invasion Cancer Metastasis Rev. 28 2009 15 33
2. L.A. Liotta, and E. Kohn Anoikis: cancer and the homeless cell Nature 430 2004 973 974
3. S. Sakamoto, and N. Kyprianou Targeting anoikis resistance in prostate cancer metastasis Mol. Aspects Med. 31 2010 205 214
4. G. Pani, E. Giannoni, T. Galeotti, and P. Chiarugi Redox-based escape mechanism from death: the cancer lesson Antioxid. Redox Signal. 11 2009 2791 2806
5. E. Giannoni, F. Buricchi, G. Grimaldi, M. Parri, F. Cialdai, M.L. Taddei, G. Raugei, G. Ramponi, and P. Chiarugi Redox regulation of anoikis: reactive oxygen species as essential mediators of cell survival Cell Death Differ. 15 2008 867 878
6. M.G. Vander Heiden, L.C. Cantley, and C.B. Thompson Understanding the Warburg effect: the metabolic requirements of cell proliferation Science (New York, N. Y.) 324 2009 1029 1033
7. C.M. Diaz-Montero, J.N. Wygant, and B.W. McIntyre PI3-K/Akt-mediated anoikis resistance of human osteosarcoma cells requires Src activation Eur. J. Cancer 42 2006 1491 1500
8. M.S. Duxbury, H. Ito, E. Benoit, T. Waseem, S.W. Ashley, and E.E. Whang A novel role for carcinoembryonic antigen-related cell adhesion molecule 6 as a determinant of gemcitabine chemoresistance in pancreatic adenocarcinoma cells Cancer Res. 64 2004 3987 3993
9. E. Giannoni, T. Fiaschi, G. Ramponi, and P. Chiarugi Redox regulation of anoikis resistance of metastatic prostate cancer cells: key role for Src and EGFR-mediated pro-survival signals Oncogene 28 2009 2074 2086
10. R.B. Robey, and N. Hay Is Akt the "Warburg kinase"? - Akt-energy metabolism interactions and oncogenesis Semin. Cancer Biol. 19 2009 25 31
11. O. Warburg On the origin of cancer cells Science (New York, N. Y.) 123 1956 309 314
12. A. Ziegler, M. von Kienlin, M. Decorps, and C. Remy High glycolytic activity in rat glioma demonstrated in vivo by correlation peak 1H magnetic resonance imaging Cancer Res. 61 2001 5595 5600
13. M. Fanciulli, T. Bruno, S. Castiglione, C. Del Carlo, M.G. Paggi, and A. Floridi Glucose metabolism in adriamycin-sensitive and -resistant LoVo human colon carcinoma cells Oncol. Res. 5 1993 357 362
14. K.A. Brand, and U. Hermfisse Aerobic glycolysis by proliferating cells: a protective strategy against reactive oxygen species FASEB J. 11 1997 388 395
15. A.E. Vaughn, and M. Deshmukh Glucose metabolism inhibits apoptosis in neurons and cancer cells by redox inactivation of cytochrome c Nat. Cell Biol. 10 2008 1477 1483
16. J.W. Kim, and C.V. Dang Multifaceted roles of glycolytic enzymes Trends Biochem. Sci. 30 2005 142 150
17. J.C. Valle-Casuso, A. Gonzalez-Sanchez, J.M. Medina, and A. Tabernero HIF-1 and c-Src mediate increased glucose uptake induced by endothelin-1 and connexin43 in astrocytes PLoS One 7 2012 e32448
18. S. Sebastian, and U.W. Kenkare Expression of two type II-like tumor hexokinase RNA transcripts in cancer cell lines Tumour Biol. 19 1998 253 260
19. A. Marin-Hernandez, S. Rodriguez-Enriquez, P.A. Vital-Gonzalez, F.L. Flores-Rodriguez, M. Macias-Silva, M. Sosa-Garrocho, and R. Moreno-Sanchez Determining and understanding the control of glycolysis in fast-growth tumor cells. Flux control by an over-expressed but strongly product-inhibited hexokinase FEBS J. 273 2006 1975 1988
20. J.E. Wilson Isozymes of mammalian hexokinase: structure, subcellular localization and metabolic function J. Exp. Biol. 206 2003 2049 2057
21. S.P. Mathupala, Y.H. Ko, and P.L. Pedersen Hexokinase II: cancer's double-edged sword acting as both facilitator and gatekeeper of malignancy when bound to mitochondria Oncogene 25 2006 4777 4786
22. C.U. Lago, H.J. Sung, W. Ma, P.Y. Wang, and P.M. Hwang p53, aerobic metabolism, and cancer Antioxid. Redox Signal. 15 2011 1739 1748
23. R. Moreno-Sanchez, S. Rodriguez-Enriquez, A. Marin-Hernandez, and E. Saavedra Energy metabolism in tumor cells FEBS J. 274 2007 1393 1418
24. C.L. Neary, and J.G. Pastorino Nucleocytoplasmic shuttling of hexokinase II in a cancer cell Biochem. Biophys. Res. Commun. 394 2010 1075 1081
25. J.S. Moon, W.J. Jin, J.H. Kwak, H.J. Kim, M.J. Yun, J.W. Kim, S.W. Park, and K.S. Kim Androgen stimulates glycolysis for de novo lipid synthesis by increasing the activities of hexokinase 2 and 6-phosphofructo-2-kinase/fructose- 2,6-bisphosphatase 2 in prostate cancer cells Biochem. J. 433 2011 225 233
26. H.N. Li, F.F. Nie, W. Liu, Q.S. Dai, N. Lu, Q. Qi, Z.Y. Li, Q.D. You, and Q.L. Guo Apoptosis induction of oroxylin A in human cervical cancer HeLa cell line in vitro and in vivo Toxicology 257 2009 80 85
27. Y. Sun, N. Lu, Y. Ling, Y. Gao, Y. Chen, L. Wang, R. Hu, Q. Qi, W. Liu, Y. Yang, Q. You, and Q. Guo Oroxylin A suppresses invasion through down-regulating the expression of matrix metalloproteinase-2/9 in MDA-MB-435 human breast cancer cells Eur. J. Pharmacol. 603 2009 22 28
28. H.B. Li, and F. Chen Isolation and purification of baicalein, wogonin and oroxylin A from the medicinal plant Scutellaria baicalensis by high-speed counter-current chromatography J. Chromatogr. A 1074 2005 107 110
29. O. Goundiam, M.D. Nagel, and M. Vayssade Growth and survival signalling in B16F10 melanoma cells in 3D culture Cell Biol. Int. 34 2010 385 391
30. L. Wei, N. Lu, Q. Dai, J. Rong, Y. Chen, Z. Li, Q. You, and Q. Guo Different apoptotic effects of wogonin via induction of H(2)O(2) generation and Ca(2 +) overload in malignant hepatoma and normal hepatic cells J. Cell. Biochem. 111 2010 1629 1641
31. L. Zhao, Q.L. Guo, Q.D. You, Z.Q. Wu, and H.Y. Gu Gambogic acid induces apoptosis and regulates expressions of Bax and Bcl-2 protein in human gastric carcinoma MGC-803 cells Biol. Pharm. Bull. 27 2004 998 1003
32. T.C. Leite, R.G. Coelho, D. Da Silva, W.S. Coelho, M.M. Marinho-Carvalho, and M. Sola-Penna Lactate downregulates the glycolytic enzymes hexokinase and phosphofructokinase in diverse tissues from mice FEBS Lett. 585 2011 92 98
33. M. Warmuth, R. Damoiseaux, Y. Liu, D. Fabbro, and N. Gray SRC family kinases: potential targets for the treatment of human cancer and leukemia Curr. Pharm. Des. 9 2003 2043 2059
34. H.Y. Yang, L. Zhao, Z. Yang, Q. Zhao, L. Qiang, J. Ha, Z.Y. Li, Q.D. You, and Q.L. Guo Oroxylin A reverses multi-drug resistance of human hepatoma BEL7402/5-FU cells via downregulation of P-glycoprotein expression by inhibiting NF-kappaB signaling pathway Mol. Carcinog. 51 2012 185 195
35. W. Liu, R. Mu, F.F. Nie, Y. Yang, J. Wang, Q.S. Dai, N. Lu, Q. Qi, J.J. Rong, R. Hu, X.T. Wang, Q.D. You, and Q.L. Guo MAC-related mitochondrial pathway in oroxylin-A-induced apoptosis in human hepatocellular carcinoma HepG2 cells Cancer Lett. 284 2009 198 207
36. A. Brouquet, P. Taleb, A.S. Lot, A. Beauchet, C. Julie, G. Prevost, B. Nordlinger, and C. Penna A model of primary culture of colorectal cancer and liver metastasis to predict chemosensitivity J. Surg. Res. 166 2011 247 254
37. V. Pongrakhananon, U. Nimmannit, S. Luanpitpong, Y. Rojanasakul, and P. Chanvorachote Curcumin sensitizes non-small cell lung cancer cell anoikis through reactive oxygen species-mediated Bcl-2 downregulation Apoptosis 15 2010 574 585
38. Z. Li, J. Zhao, Y. Du, H.R. Park, S.Y. Sun, L. Bernal-Mizrachi, A. Aitken, F.R. Khuri, and H. Fu Down-regulation of 14-3-3zeta suppresses anchorage-independent growth of lung cancer cells through anoikis activation Proc. Natl. Acad. Sci. U. S. A. 105 2008 162 167
39. A. Aleshin, and R.S. Finn SRC: a century of science brought to the clinic Neoplasia (New York, N. Y.) 12 2010 599 607
40. J.S. Nam, Y. Ino, M. Sakamoto, and S. Hirohashi Src family kinase inhibitor PP2 restores the E-cadherin/catenin cell adhesion system in human cancer cells and reduces cancer metastasis Clin. Cancer Res. 8 2002 2430 2436
41. X.N. Meng, Y. Jin, Y. Yu, J. Bai, G.Y. Liu, J. Zhu, Y.Z. Zhao, Z. Wang, F. Chen, K.Y. Lee, and S.B. Fu Characterisation of fibronectin-mediated FAK signalling pathways in lung cancer cell migration and invasion Br. J. Cancer 101 2009 327 334
42. D. Trachootham, J. Alexandre, and P. Huang Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach? Nat. Rev. Drug Discov. 8 2009 579 591
43. R. Ley, K.E. Ewings, K. Hadfield, E. Howes, K. Balmanno, and S.J. Cook Extracellular signal-regulated kinases 1/2 are serum-stimulated "Bim(EL) kinases" that bind to the BH3-only protein Bim(EL) causing its phosphorylation and turnover J. Biol. Chem. 279 2004 8837 8847
44. D. Hanahan, and R.A. Weinberg Hallmarks of cancer: the next generation Cell 144 2011 646 674
45. J.P. Bolanos, A. Almeida, and S. Moncada Glycolysis: a bioenergetic or a survival pathway? Trends Biochem. Sci. 35 2010 145 149
46. R. Moreno-Sanchez, S. Rodriguez-Enriquez, E. Saavedra, A. Marin-Hernandez, and J.C. Gallardo-Perez The bioenergetics of cancer: is glycolysis the main ATP supplier in all tumor cells? Biofactors 35 2009 209 225
47. H. Pelicano, D.S. Martin, R.H. Xu, and P. Huang Glycolysis inhibition for anticancer treatment Oncogene 25 2006 4633 4646
48. R.S. Balaban, and J.P. Bader Studies on the relationship between glycolysis and (Na + + K +)-ATPase in cultured cells Biochim. Biophys. Acta 804 1984 419 426
49. Z.T. Schafer, A.R. Grassian, L. Song, Z. Jiang, Z. Gerhart-Hines, H.Y. Irie, S. Gao, P. Puigserver, and J.S. Brugge Antioxidant and oncogene rescue of metabolic defects caused by loss of matrix attachment Nature 461 2009 109 113
50. S. Weinhouse The Warburg hypothesis fifty years later Z. Krebsforsch. Klin. Onkol. Cancer Res. Clin. Oncol. 87 1976 115 126
51. V.R. Fantin, J. St-Pierre, and P. Leder Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance Cancer Cell 9 2006 425 434
52. M. Serrano, A.W. Lin, M.E. McCurrach, D. Beach, and S.W. Lowe Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a Cell 88 1997 593 602
53. S.P. Mathupala, Y.H. Ko, and P.L. Pedersen The pivotal roles of mitochondria in cancer: Warburg and beyond and encouraging prospects for effective therapies Biochim. Biophys. Acta 1797 2010 1225 1230
54. T. Tohma, S. Okazumi, H. Makino, A. Cho, R. Mochiduki, K. Shuto, H. Kudo, K. Matsubara, H. Gunji, and T. Ochiai Relationship between glucose transporter, hexokinase and FDG-PET in esophageal cancer Hepatogastroenterology 52 2005 486 490
55. J.G. Pastorino, and J.B. Hoek Regulation of hexokinase binding to VDAC J. Bioenerg. Biomembr. 40 2008 171 182
56. I.V. Perevoshchikova, S.D. Zorov, E.A. Kotova, D.B. Zorov, and Y.N. Antonenko Hexokinase inhibits flux of fluorescently labeled ATP through mitochondrial outer membrane porin FEBS Lett. 584 2010 2397 2402
57. D.G. Brdiczka, D.B. Zorov, and S.S. Sheu Mitochondrial contact sites: their role in energy metabolism and apoptosis Biochim. Biophys. Acta 1762 2006 148 163
58. Y.H. Ko, B.L. Smith, Y. Wang, M.G. Pomper, D.A. Rini, M.S. Torbenson, J. Hullihen, and P.L. Pedersen Advanced cancers: eradication in all cases using 3-bromopyruvate therapy to deplete ATP Biochem. Biophys. Res. Commun. 324 2004 269 275